Siltuximab - EUSA Pharma/Janssen Biotech
At a glance
- Drug Originator Janssen Biotech
- Drug Licenced by BeiGene
- Drug Class Anti-inflammatories; Antineoplastics; Immunotherapies; Monoclonal antibodies
- Mechanism of Action Interleukin 6 inhibitors
- USA Patent Applicants EUSA PHARMA LIMITED; JANSSEN BIOTECH
- USA Patents 30
- BLAs 1
- International Patents 163
Disclaimer